For the Quarter Ending March 2025
North America
During the January to March 2025 quarter, the North American Vitamin B6 market experienced a modest average price increase of about 0.51% from previous quarter. The market tone was generally steady and was driven by stable demand from pharmaceutical and personal care sectors. Seasonal change from winter to early spring supported moderate procurement activity as manufacturers planned ahead for new production cycles.
Despite a relatively calm trading environment the tariff measures on certain imported categories provided some price support for locally sourced Vitamin B6. Inventory levels remained comfortably placed, with no significant overhang from the previous quarter. This allowed Vitamin B6 suppliers and Vitamin B6 distributors to manage supply efficiently without causing sharp market reactions.
The nutraceutical segment maintained steady offtakes, whereas the food and beverage sector operated cautiously amid controlled purchasing schedules. Overall, the combination of seasonal transition and steady downstream consumption helped Vitamin B6 prices hold firm in the region. Market sentiment remained optimistic throughout the first quarter of 2025 which was supported by consistent logistics and strategic buying across key sectors.
Asia Pacific
In the first quarter of 2025, the Asia Pacific market recorded a slight rise of around 0.90% in average Vitamin B6 prices. The period was marked by moderate activity in the Vitamin B6 market, with some support coming from downstream demand in pharmaceutical and nutraceutical sectors. The seasonal transition from winter to spring played a subtle role in shifting procurement patterns. Many Vitamin B6 suppliers in the region kept inventory levels steady and avoided large stock movements during the Chinese Lunar New Year holidays, which affected overall production schedules.
Being a key exporting country, any production adjustment in China typically influences the broader Asia Pacific Vitamin B6 market sentiment. The downstream sectors saw a stable performance, though food and beverage manufacturers showed slightly cautious buying due to existing stock availability. Smooth logistics and well-managed inventory positions limited any sharp fluctuations. Anticipation of upcoming production cycles further encouraged strategic procurement by Vitamin B6 distributors. Overall, the market followed a balanced pace in the first quarter of 2025, with steady price growth reflecting well-maintained market fundamentals.
Europe
The European market saw a mild quarterly increase of around 0.37% in Vitamin B6 prices during the first quarter of 2025. The region observed steady procurement patterns from pharmaceutical and food-related sectors, whereas personal care applications remained moderately active. A balanced supply situation, combined with controlled inventory positions helped in keeping market sentiment stable.
Many Vitamin B6 distributors in the region adopted a careful procurement approach and avoided excess stock build-up while maintaining essential supplies. Although the increase was marginal, it reflected consistent demand, particularly from nutraceutical manufacturers who planned ahead for seasonal product launches.
The overall Vitamin B6 market in Europe was shaped by steady logistics and anticipation of upcoming production schedules in key manufacturing hubs. Market players responded cautiously which helped to keep price movements limited within a narrow range. The price increase aligned with soft regional demand and balanced stock levels, helping the market avoid any volatility. As downstream sectors continued routine operations in first quarter of 2025, the market kept a composed tone with suppliers managing offers in line with stable regional trends.
For the Quarter Ending December 2024
North America
During Q4 2024, the Vitamin B6 market in North America maintained relative stability with a slight downward bias. October saw prices holding steady as balanced supply-demand fundamentals prevailed in the market. Buyers maintained routine procurement patterns while manufacturers reported normal operating rates. The nutraceutical and animal feed sectors continued their consistent demand, helping maintain price levels with only marginal softening.
November continued the stable trend with a slight downward movement as market fundamentals remained largely unchanged. Supply chains operated smoothly while demand from end-users remained consistent. Buyers continued their regular procurement activities, though some negotiated minor price concessions. Distributors reported comfortable inventory positions, leading to small price adjustments downward. The market witnessed systematic trading activity as end-users maintained routine buying patterns.
December saw the continuation of stable to soft pricing as year-end activities proceeded normally. Domestic suppliers maintained steady production rates, though facing minimal pressure to adjust prices marginally downward. The market demonstrated typical year-end patterns with slight price erosion, as buyers maintained regular consumption rates. Manufacturers reported balanced supply-demand conditions, with minor price adjustments reflecting the marginally softer market sentiment through quarter-end.
APAC
In Q4 2024, Vitamin B6 prices in APAC markets showed stability with a gentle downward trend. October maintained steady price levels as manufacturers balanced production with market requirements. Producers reported stable production costs, while consistent inquiries from various sectors helped maintain overall price levels with minimal decline. The market witnessed regular trading activity as buyers followed established procurement patterns.
November saw prices continuing their stable to soft trend. Manufacturers maintained steady operations while managing minor downward price adjustments amid adequate supply conditions. Regional trading activity proceeded at routine levels, with slight price concessions offered by suppliers. Production facilities reported normal operations, while export inquiries remained steady despite the marginal price decline.
December maintained the stable to soft trend as manufacturers continued routine operations. Several facilities reported normal production rates amid typical year-end demand. Export prices showed minimal softening, influenced by steady but slightly weaker inquiry levels from international markets. The domestic market maintained its usual vigor despite marginal price erosion, as end-users continued regular procurement patterns.
Europe
In Q4 2024, Vitamin B6 prices in Germany and broader European markets demonstrated similar stability with slight softening. October began with steady price levels as the market maintained equilibrium between supply and demand. European producers operated at normal rates while managing minor downward price adjustments. The market witnessed routine trading as distributors maintained regular procurement patterns.
November continued the stable trend with marginal price decline as market conditions remained balanced. Buyers maintained regular procurement while negotiating slight price reductions amid adequate supply availability. The market witnessed normal trading as distributors followed established buying patterns. Several buyers reported comfortable stock positions, contributing to the minimal downward price pressure.
December's market dynamics remained largely unchanged, though with continued slight softening. Regular consumption patterns across end-use sectors helped maintain overall stability, despite minor price erosion through quarter-end. Year-end activities proceeded normally, with key buyers maintaining routine procurement volumes. Manufacturers reported steady operations and well-managed inventory positions, while logistics activities continued smoothly through the holiday season, with prices showing minimal decline.
